Safety And Efficacy Of Tropifexor In Patients With Fibrotic Nonalcoholic Steatohepatitis: 48-Week Results From Part C Of The Phase 2 Flight-Fxr Study

HEPATOLOGY(2020)

引用 17|浏览15
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要